Japonicin-2LF

General Information


DCTPep ID  DCTPep03797

Peptide Name   Japonicin-2LF

Sequence  FIVPSIFLLKKAFCIALKKC

Sequence Length  20

UniProt ID  A0A482F245 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C112H184N24O22S2

Absent amino acids  DEGHMNQRTWY

Theoretical pI  9.70

Acidic residues  0

Basic residues  4

Polar residues  3

Molecular weight (Average)  2282.96

Molecular weight (Monoisotopic)  2281.35

Common amino acids  K

Net charge  4

Instability index (II)  16.02

Aliphatic index  141.50

Grand average of hydropathicity (GRAVY)  1.405

Half Life 
  1.1 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.055, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30802593

Title  A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12644

DCTPep is developed by Dr.Zheng's team.